T3 Pharmaceuticals wins W.A. de Vigier Award

T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel is developing a targeted cancer therapy using bacteria.

...

Roche takes Switzerland to number one for patents

In 2018, no other country in Europe saw more patents filed relative to population size than Switzerland. This has been found by a new report from the European Patent Office. The most Swiss patent applications...

Basel scientists develop DNA storage device

Basel – Scientists at the ETH Zurich’s Department of Biosystems in Basel have developed a storage mechanism that can provide insight into the history of cellular processes. It is the first device of its kind.

...

Novo Holdings invests in Polyphor

Allschwil BL – Danish company Novo Holdings is investing 6.8 million Swiss francs in the biopharmaceutical Polyphor from the canton of Basel-Landschaft. As a result, it hopes to accelerate the development of novel antibiotics. Polyphor recently went public...